Body composition and sarcopenia assessment
Automatic detection and quantification of muscle mass in CT scans, providing crucial nutritional metrics for cancer patients and improving treatment efficacy.

Advanced AI-powered body composition analysis and tumor segmentation from medical images.
Nucleo's advanced AI technology streamlines clinical workflows across three critical areas for oncology care.
Automatic detection and quantification of muscle mass in CT scans, providing crucial nutritional metrics for cancer patients and improving treatment efficacy.
Precise and consistent measurement of tumor lesions in CT scans, enabling accurate tracking of disease progression and treatment response.
Automated classification of lesions according to RECIST criteria, streamlining the evaluation process and enhancing reporting consistency.
Our platform delivers incredible performance in seconds. For example, in the body composition assessment task, our accuracy, measured in Dice score similarity, is well above that of the widely used Bioelectrical Impedance Analysis (BIA).
Interested in joining our pilot program or learning more about Nucleo? Reach out to us today.